These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1148 related articles for article (PubMed ID: 17440955)
1. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955 [TBL] [Abstract][Full Text] [Related]
2. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627 [TBL] [Abstract][Full Text] [Related]
3. The role of sentinel node biopsy in ductal carcinoma in situ of the breast. Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312 [TBL] [Abstract][Full Text] [Related]
4. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S Breast J; 2008; 14(1):55-60. PubMed ID: 18186866 [TBL] [Abstract][Full Text] [Related]
5. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases. Han JS; Molberg KH; Sarode V Breast J; 2011; 17(3):223-9. PubMed ID: 21545433 [TBL] [Abstract][Full Text] [Related]
6. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952 [TBL] [Abstract][Full Text] [Related]
7. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit. Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346 [TBL] [Abstract][Full Text] [Related]
8. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928 [TBL] [Abstract][Full Text] [Related]
9. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy. Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G Breast J; 2008; 14(2):135-40. PubMed ID: 18315691 [TBL] [Abstract][Full Text] [Related]
10. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650 [TBL] [Abstract][Full Text] [Related]
11. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134 [TBL] [Abstract][Full Text] [Related]
12. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492 [TBL] [Abstract][Full Text] [Related]
13. [Sentinel lymph node biopsy in breast cancer]. Schlichting E; Harr ME; Sauer T; Babovic A; Kåresen R Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2098-100. PubMed ID: 16932777 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Kurniawan ED; Rose A; Mou A; Buchanan M; Collins JP; Wong MH; Miller JA; Mann GB Arch Surg; 2010 Nov; 145(11):1098-104. PubMed ID: 21079099 [TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ: value of sentinel lymph node biopsy. Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457 [TBL] [Abstract][Full Text] [Related]
16. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy. Tan JC; McCready DR; Easson AM; Leong WL Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256 [TBL] [Abstract][Full Text] [Related]
17. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092 [TBL] [Abstract][Full Text] [Related]
18. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A; Craig PH; Silverstein MJ Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018 [TBL] [Abstract][Full Text] [Related]
19. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]